{"transactions":[{"id":4633213,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-10-03T00:13:27.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":false,"shares":1360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":1361,"derivative":{"underlying":"Common Stock","underlying_shares":1360},"source":{"system":"sec-edgar","filing":"0000905148-26-004336","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826004336/form4.xml","form_type":"4"}},{"id":4633212,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T00:13:27.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":true,"shares":1360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":26743,"source":{"system":"sec-edgar","filing":"0000905148-26-004336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826004336/form4.xml","form_type":"4"}},{"id":719241,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-07-02T20:27:45.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":1361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":2721,"derivative":{"underlying":"Common Stock","underlying_shares":1361},"source":{"system":"sec-edgar","filing":"0000905148-26-003146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826003146/form4.xml","form_type":"4"}},{"id":719240,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-07-02T20:27:45.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":1361,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":25383,"source":{"system":"sec-edgar","filing":"0000905148-26-003146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826003146/form4.xml","form_type":"4"}},{"id":821072,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:52:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":1361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":4082,"derivative":{"underlying":"Common Stock","underlying_shares":1361},"source":{"system":"sec-edgar","filing":"0000905148-26-001495","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826001495/form4.xml","form_type":"4"}},{"id":821071,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-04-02T20:52:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":1361,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":24022,"source":{"system":"sec-edgar","filing":"0000905148-26-001495","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826001495/form4.xml","form_type":"4"}},{"id":948237,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":1143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vested in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vested in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1143},"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":948236,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":948235,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":5443,"derivative":{"underlying":"Common Stock","underlying_shares":5443},"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":948234,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":1143,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":22661,"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":1028164,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:04:20.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":false,"shares":1144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1143,"derivative":{"underlying":"Common Stock","underlying_shares":1144},"source":{"system":"sec-edgar","filing":"0000905148-25-003485","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825003485/form4.xml","form_type":"4"}},{"id":1028163,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2025-10-02T20:04:20.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":true,"shares":1144,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":21518,"source":{"system":"sec-edgar","filing":"0000905148-25-003485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825003485/form4.xml","form_type":"4"}},{"id":1096299,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-07-02T20:33:08.000Z","date":"2025-06-30","kind":"exercise","planned":false,"acquired":false,"shares":22874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":45747,"derivative":{"underlying":"Common Stock","underlying_shares":22874},"source":{"system":"sec-edgar","filing":"0000905148-25-002317","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825002317/form4.xml","form_type":"4"}},{"id":1096298,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2025-07-02T20:33:08.000Z","date":"2025-06-30","kind":"exercise","planned":false,"acquired":true,"shares":22874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":407486,"source":{"system":"sec-edgar","filing":"0000905148-25-002317","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825002317/form4.xml","form_type":"4"}},{"id":1137996,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-22T20:16:29.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":42010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":42010,"derivative":{"exercise_price":0.2708,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":42010},"source":{"system":"sec-edgar","filing":"0000905148-25-001896","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825001896/form4.xml","form_type":"4"}},{"id":1137995,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:16:29.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":68621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":68621,"derivative":{"underlying":"Common Stock","underlying_shares":68621},"source":{"system":"sec-edgar","filing":"0000905148-25-001896","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825001896/form4.xml","form_type":"4"}},{"id":1184583,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T20:25:49.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":46686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in full on March 31, 2025, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in full on March 31, 2025, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46686},"source":{"system":"sec-edgar","filing":"0000905148-25-001047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825001047/form4.xml","form_type":"4"}},{"id":1184582,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2025-04-02T20:25:49.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":46686,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":384612,"source":{"system":"sec-edgar","filing":"0000905148-25-001047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825001047/form4.xml","form_type":"4"}},{"id":1346388,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T20:48:49.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.57,"value":314000.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by the reporting person from Jack Schuler, a member of the issuer's board of directors, in a private transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust."}],"balance_after":653224,"source":{"system":"sec-edgar","filing":"0001104659-24-125217","document":"tm2430099-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924125217/tm2430099-2_4seq1.xml","form_type":"4"}},{"id":1374533,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2024-11-06T20:16:09.000Z","date":"2024-11-05","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":1.3828,"value":103710.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3461 to $1.4186, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2153298,"source":{"system":"sec-edgar","filing":"0000905148-24-002948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824002948/form4.xml","form_type":"4"}},{"id":1504282,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-05-23T23:12:54.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":5435,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":217400},"source":{"system":"sec-edgar","filing":"0000905148-24-001605","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824001605/form4.xml","form_type":"4"}},{"id":1504281,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T23:12:54.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001605","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824001605/form4.xml","form_type":"4"}},{"id":1504280,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2024-05-23T23:12:54.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":46686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":46686,"derivative":{"underlying":"Common Stock","underlying_shares":46686},"source":{"system":"sec-edgar","filing":"0000905148-24-001605","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824001605/form4.xml","form_type":"4"}},{"id":1504279,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2024-05-23T23:12:54.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":217400,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993)."}],"balance_after":4829611,"source":{"system":"sec-edgar","filing":"0000905148-24-001605","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824001605/form4.xml","form_type":"4"}},{"id":1508170,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-21T19:02:04.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served."}],"balance_after":66667,"derivative":{"underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001104659-24-063965","document":"tm2415084-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924063965/tm2415084-4_4seq1.xml","form_type":"4"}},{"id":1544816,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-09T23:33:48.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":5435,"price":46,"value":250010.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":5435,"derivative":{"underlying":"Common Stock","underlying_shares":217400},"source":{"system":"sec-edgar","filing":"0000905148-24-001140","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824001140/form4.xml","form_type":"4"}},{"id":1671548,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-01-25T16:10:26.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,666 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."}],"balance_after":16666,"derivative":{"exercise_price":1.65,"exercise_date":"2024-01-23","expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001104659-24-006670","document":"tm244005-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006670/tm244005-5_4seq1.xml","form_type":"4"}},{"id":1671547,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T16:10:26.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,666 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."}],"balance_after":453224,"source":{"system":"sec-edgar","filing":"0001104659-24-006670","document":"tm244005-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006670/tm244005-5_4seq1.xml","form_type":"4"}},{"id":1694049,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:14:28.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":134262,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514824000038/form4.xml","form_type":"4"}},{"id":1814124,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2023-08-07T21:32:10.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":61728,"price":1.62,"value":99999.36,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":4612211,"source":{"system":"sec-edgar","filing":"0000905148-23-000626","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514823000626/form4.xml","form_type":"4"}},{"id":1842391,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-29T17:59:33.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":236842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 28, 2023, the reporting person was granted RSUs which vest in equal amounts each year for 5 years, with the first installment vesting on June 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":236842,"derivative":{"underlying":"Common Stock","underlying_shares":236842},"source":{"system":"sec-edgar","filing":"0001628280-23-023938","document":"wk-form4_1688075963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023023938/wk-form4_1688075963.xml","form_type":"4"}},{"id":1872793,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-01T18:27:57.000Z","date":"2023-05-29","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following his departure from the issuer's board of\ndirectors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":78947,"derivative":{"underlying":"Common Stock","underlying_shares":78947},"source":{"system":"sec-edgar","filing":"0001628280-23-020566","document":"wk-form4_1685658466.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023020566/wk-form4_1685658466.xml","form_type":"4"}},{"id":1878691,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2023-05-25T22:22:13.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":28873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":28873,"derivative":{"underlying":"Common Stock","underlying_shares":28873},"source":{"system":"sec-edgar","filing":"0001140361-23-026720","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000114036123026720/form4.xml","form_type":"4"}},{"id":2063784,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2023-01-05T21:31:23.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":4878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":150711,"derivative":{"underlying":"Common Stock","underlying_shares":4878},"source":{"system":"sec-edgar","filing":"0001140361-23-000672","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000114036123000672/form4.xml","form_type":"4"}},{"id":2069630,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T23:21:11.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":145833,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001140361-23-000520","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000114036123000520/form4.xml","form_type":"4"}},{"id":2109155,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2022-11-21T23:03:11.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":1739130,"price":1.15,"value":1999999.5,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":4550483,"source":{"system":"sec-edgar","filing":"0001140361-22-042602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000114036122042602/form4.xml","form_type":"4"}},{"id":2248650,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2022-06-02T16:21:35.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":75949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on May 31, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following his departure from the issuer's board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":75949,"derivative":{"underlying":"Common Stock","underlying_shares":75949},"source":{"system":"sec-edgar","filing":"0001628280-22-016061","document":"wf-form4_165420127815825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828022016061/wf-form4_165420127815825.xml","form_type":"4"}},{"id":2255734,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2022-05-26T20:15:44.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":83333,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001140361-22-020782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000114036122020782/form4.xml","form_type":"4"}},{"id":2299591,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2022-04-11T20:39:39.000Z","date":"2022-04-07","kind":"purchase","acquired":true,"shares":279329,"price":1.79,"value":499998.91,"ownership":{"direct":true},"balance_after":337926,"source":{"system":"sec-edgar","filing":"0001567619-22-008354","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000156761922008354/doc1.xml","form_type":"4"}},{"id":2450994,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2022-01-04T21:59:22.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":22988,"price":4.35,"value":99997.8,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":52988,"source":{"system":"sec-edgar","filing":"0001567619-22-000275","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000156761922000275/doc1.xml","form_type":"4"}},{"id":2450993,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2022-01-04T21:59:22.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":137931,"price":4.35,"value":599999.85,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2078298,"source":{"system":"sec-edgar","filing":"0001567619-22-000275","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000156761922000275/doc1.xml","form_type":"4"}},{"id":2478264,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T15:57:04.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":21702,"price":7.68,"value":166671.36,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the third and final tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The third and final tranche of the offering closed on September 30, 2021."}],"balance_after":4365585,"source":{"system":"sec-edgar","filing":"0001628280-21-024838","document":"wf-form4_163916981210596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828021024838/wf-form4_163916981210596.xml","form_type":"4"}},{"id":2496483,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2021-11-24T19:57:39.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":10000,"price":6.1753,"value":61753.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.74 to $6.38, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1940367,"source":{"system":"sec-edgar","filing":"0001567619-21-021148","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000156761921021148/doc1.xml","form_type":"4"}},{"id":2501402,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2021-11-22T20:33:34.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":9497,"price":6.3409,"value":60219.5273,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.14 to $6.50, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1930367,"source":{"system":"sec-edgar","filing":"0001567619-21-020954","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000156761921020954/doc1.xml","form_type":"4"}},{"id":2593924,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2021-08-23T19:01:57.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":8396,"price":8.0383,"value":67489.5668,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $8.325, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1920870,"source":{"system":"sec-edgar","filing":"0001567619-21-016211","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000156761921016211/doc1.xml","form_type":"4"}},{"id":2596569,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2021-08-19T19:00:33.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":1604,"price":7.1174,"value":11416.3096,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.94 to $7.25, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 98 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1912474,"source":{"system":"sec-edgar","filing":"0000905148-21-000612","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514821000612/form4.xml","form_type":"4"}},{"id":2648421,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to buy)","published_at":"2021-07-01T22:21:06.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":34385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on March 31, 2022."}],"balance_after":34385,"derivative":{"exercise_price":13.72,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":34385},"source":{"system":"sec-edgar","filing":"0000905148-21-000536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514821000536/form4.xml","form_type":"4"}},{"id":2699981,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T21:59:22.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":35168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on May 20, 2022."}],"balance_after":35168,"derivative":{"exercise_price":7.68,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":35168},"source":{"system":"sec-edgar","filing":"0001104659-21-071495","document":"tm2117458d4_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465921071495/tm2117458d4_form4.xml","form_type":"4"}},{"id":2750963,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-13T16:20:34.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":21701,"price":7.68,"value":166663.68,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the second tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The second tranche of the offering closed on April 9, 2021."}],"balance_after":4343883,"source":{"system":"sec-edgar","filing":"0001628280-21-006838","document":"wf-form4_161834521821855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828021006838/wf-form4_161834521821855.xml","form_type":"4"}},{"id":2841739,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T19:57:01.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":21701,"price":7.68,"value":166663.68,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the first tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The first tranche of the offering closed on February 19, 2021."}],"balance_after":4322182,"source":{"system":"sec-edgar","filing":"0001104659-21-026983","document":"tm217603d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465921026983/tm217603d3_4.xml","form_type":"4"}},{"id":2952265,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-12-10T02:39:41.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":23440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 12 successive, equal monthly installments measured from April 1, 2020."}],"balance_after":11718,"derivative":{"exercise_price":6.83,"expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":23440},"source":{"system":"sec-edgar","filing":"0000905148-20-001262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514820001262/form4.xml","form_type":"4"}},{"id":2952264,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-12-10T02:39:41.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":35157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested in 12 successive, equal monthly installments measured from April 1, 2019."}],"balance_after":1,"derivative":{"exercise_price":6.83,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":35157},"source":{"system":"sec-edgar","filing":"0000905148-20-001262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514820001262/form4.xml","form_type":"4"}},{"id":2952263,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-12-10T02:39:41.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":23440,"price":6.83,"value":160095.2,"ownership":{"direct":true},"balance_after":58597,"source":{"system":"sec-edgar","filing":"0000905148-20-001262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514820001262/form4.xml","form_type":"4"}},{"id":2952262,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-12-10T02:39:41.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":35157,"price":6.83,"value":240122.31,"ownership":{"direct":true},"balance_after":35157,"source":{"system":"sec-edgar","filing":"0000905148-20-001262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514820001262/form4.xml","form_type":"4"}},{"id":2995363,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"3% Convertible Debt due June 2021","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"price":0,"reported_value":900000,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon completion of the IPO, the outstanding principal and unpaid accrued interest on this Convertible Debt was automatically converted into Common Stock.  Share numbers gave effect to such conversion; debt amount reflects principal only, no interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"exercise_price":14.4,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":64416},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995362,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"3% Convertible Debt due June 2021","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"price":0,"reported_value":1150000,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon completion of the IPO, the outstanding principal and unpaid accrued interest on this Convertible Debt was automatically converted into Common Stock.  Share numbers gave effect to such conversion; debt amount reflects principal only, no interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":14.4,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":81600},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995361,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"3% Convertible Debt due June 2021","published_at":"2020-11-03T23:25:05.000Z","date":"2020-06-23","kind":"grant","acquired":true,"price":0,"reported_value":150000,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This Convertible Debt paid interest at 3% per annum and was payable in full upon maturity through the conversion to Series H Preferred Stock at 80% of the original issuance price of $1.15 per share. On or before the maturity date and if the Convertible Debt remained unpaid, the outstanding principal and unpaid accrued interest was to be automatically converted into Common Stock at the completion of the IPO at a conversion price equal to 80% of the price per share paid for the Common Stock sold in the IPO.  Share numbers give effect to such conversion; debt amount reflects principal only, no interest."},{"field":"date","element":"transactionDate","label":"F6","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This Convertible Debt paid interest at 3% per annum and was payable in full upon maturity through the conversion to Series H Preferred Stock at 80% of the original issuance price of $1.15 per share. On or before the maturity date and if the Convertible Debt remained unpaid, the outstanding principal and unpaid accrued interest was to be automatically converted into Common Stock at the completion of the IPO at a conversion price equal to 80% of the price per share paid for the Common Stock sold in the IPO.  Share numbers give effect to such conversion; debt amount reflects principal only, no interest."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1150000,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":10527},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995360,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series H Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":4182413,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":704596},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995359,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series G Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":6711816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1130715},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995358,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series G Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":957114,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":161242},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995357,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series F Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":3055837,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":514806},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995356,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series F Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":3205681,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":540050},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995355,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series E Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":1484624,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":250109},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995354,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series E Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":809200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":136323},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995353,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series D Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":2932534,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":494033},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995352,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series D Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":42117},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995351,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series C Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":666666,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":112311},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995350,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series B-1 Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Every share of Series B-1 Preferred Stock (\"B-1 Preferred Stock\") converted into approximately 0.196 shares of Common Stock at the closing of the Issuer's IPO. Share numbers gave effect to such conversion. The B-1 Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Every share of Series B-1 Preferred Stock (\"B-1 Preferred Stock\") converted into approximately 0.196 shares of Common Stock at the closing of the Issuer's IPO. Share numbers gave effect to such conversion. The B-1 Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Every share of Series B-1 Preferred Stock (\"B-1 Preferred Stock\") converted into approximately 0.196 shares of Common Stock at the closing of the Issuer's IPO. Share numbers gave effect to such conversion. The B-1 Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":245041},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995349,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Series B Preferred Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":1454545,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":245042},"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995348,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"purchase","acquired":true,"shares":30000,"price":18,"value":540000.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995347,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":64416,"price":14.4,"value":927590.4,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":2811431,"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995346,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":81600,"price":14.4,"value":1175040.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1910968,"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995345,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":245041,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Every share of Series B-1 Preferred Stock (\"B-1 Preferred Stock\") converted into approximately 0.196 shares of Common Stock at the closing of the Issuer's IPO. Share numbers gave effect to such conversion. The B-1 Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":2747015,"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995344,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":2501974,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the sole trustee of John Patience Trust (July 23, 1993)."}],"balance_after":2501974,"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":2995343,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2020-11-03T23:25:05.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":1829368,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the \"Preferred Stock\") converted into approximately 0.1684664 shares of Issuer Common Stock (\"Common Stock\") at the closing of the Issuer's initial public offering (\"IPO\"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1829368,"source":{"system":"sec-edgar","filing":"0001209191-20-056752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000120919120056752/doc4.xml","form_type":"4"}},{"id":3073072,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-31T18:16:24.000Z","date":"2020-03-24","kind":"purchase","acquired":true,"shares":5000,"price":6.83,"value":34150.0,"ownership":{"direct":false,"nature":"By John Patience Living Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.81 to $6.85, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the \"Issuer\"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to a clerical error, the reported shares owned indirectly by the reporting person through the John Patience Living Trust dated 7/23/1993 (the \"Trust\") has been adjusted to correct an understatement of 104,270 shares.   The 104,270 shares represent (i) 59,600 shares acquired by the Trust on May 2, 2014, which were previously reported in the reporting person's Form 4 filed May 2, 2014 and inadvertently omitted in subsequent filings; (ii) 20,000 shares acquired by the Trust on December 1, 2016, which were incorrectly reported as acquired directly by the reporting person in the reporting person's Form 4 filed December 7, 2016 and in subsequent filings; and (iii) 24,670 shares acquired by the Trust on December 13, 2016, which were incorrectly reported as acquired directly by the reporting person in the reporting person's Form 4 filed December 14, 2016 and in subsequent filings."}],"balance_after":4300481,"source":{"system":"sec-edgar","filing":"0001628280-20-011379","document":"wf-form4a_159623377007067.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828020011379/wf-form4a_159623377007067.xml","form_type":"4/A","original_submission_date":"2020-03-24"}},{"id":3185361,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T12:21:01.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":13779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments, with the first installment vesting on May 1, 2020."}],"balance_after":13779,"derivative":{"exercise_price":8.33,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":13779},"source":{"system":"sec-edgar","filing":"0001628280-20-004571","document":"wf-form4_158593084397620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828020004571/wf-form4_158593084397620.xml","form_type":"4"}},{"id":3193884,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-27T21:04:59.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":12290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 was inadvertently not filed within the required time following the transaction date of April 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments, with the first installment vesting on May 1, 2019."}],"balance_after":12290,"derivative":{"exercise_price":21.02,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":12290},"source":{"system":"sec-edgar","filing":"0001628280-20-004263","document":"wf-form4_158535748088342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828020004263/wf-form4_158535748088342.xml","form_type":"4"}},{"id":3194834,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-26T15:35:19.000Z","date":"2020-03-24","kind":"purchase","acquired":true,"shares":5000,"price":6.83,"value":34150.0,"ownership":{"direct":false,"nature":"By John Patience Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.81 to $6.85, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the \"Issuer\"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":4196211,"source":{"system":"sec-edgar","filing":"0001628280-20-004093","document":"wf-form4_158525130138977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828020004093/wf-form4_158525130138977.xml","form_type":"4"}},{"id":3768957,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-13T21:40:33.000Z","date":"2018-11-08","kind":"purchase","acquired":true,"shares":10000,"price":14.96,"value":149600.0,"ownership":{"direct":false,"nature":"By John Patience Defined Benefit Pension Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.96 to $15.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the range."}],"balance_after":39411,"source":{"system":"sec-edgar","filing":"0001144204-18-059492","document":"tv506947_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420418059492/tv506947_4.xml","form_type":"4"}},{"id":3917803,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-25T16:08:36.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":1970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."}],"balance_after":3878,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1970},"source":{"system":"sec-edgar","filing":"0001692742-18-000090","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274218000090/edgardoc.xml","form_type":"4"}},{"id":3919494,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-24T16:51:01.000Z","date":"2018-05-23","kind":"exercise","acquired":false,"shares":7105,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":58.82,"exercise_date":"2009-05-29","expiration_date":"2018-05-29","underlying":"Common Stock","underlying_shares":7105},"source":{"system":"sec-edgar","filing":"0001692742-18-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274218000076/edgardoc.xml","form_type":"4"}},{"id":3919493,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T16:51:01.000Z","date":"2018-05-23","kind":"sale","acquired":false,"shares":6624,"price":63.1463,"value":418281.0912,"ownership":{"direct":true},"balance_after":150110,"source":{"system":"sec-edgar","filing":"0001692742-18-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274218000076/edgardoc.xml","form_type":"4"}},{"id":3919492,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T16:51:01.000Z","date":"2018-05-23","kind":"exercise","acquired":true,"shares":7105,"price":58.82,"value":417916.1,"ownership":{"direct":true},"balance_after":156734,"source":{"system":"sec-edgar","filing":"0001692742-18-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274218000076/edgardoc.xml","form_type":"4"}},{"id":3950450,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-02T17:19:45.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."}],"balance_after":2078,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":170},"source":{"system":"sec-edgar","filing":"0001179110-18-006059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000117911018006059/edgar.xml","form_type":"4"}},{"id":3975464,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-03T15:13:11.000Z","date":"2018-04-01","kind":"grant","acquired":true,"shares":9476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2018."}],"balance_after":9476,"derivative":{"exercise_price":22.85,"expiration_date":"2028-04-01","underlying":"Common Stock","underlying_shares":9476},"source":{"system":"sec-edgar","filing":"0001144204-18-018911","document":"tv490260_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420418018911/tv490260_4.xml","form_type":"4"}},{"id":4082553,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-01T17:00:15.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."}],"balance_after":1908,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":132},"source":{"system":"sec-edgar","filing":"0001692742-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274218000012/edgardoc.xml","form_type":"4"}},{"id":4168433,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-09T15:00:53.000Z","date":"2017-11-07","kind":"purchase","acquired":true,"shares":20000,"price":18.75,"value":375000.0,"ownership":{"direct":false,"nature":"By John Patience Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.73 to $18.75, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4191211,"source":{"system":"sec-edgar","filing":"0001144204-17-057662","document":"tv479096_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417057662/tv479096_4.xml","form_type":"4"}},{"id":4169714,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-08T15:03:37.000Z","date":"2017-11-06","kind":"purchase","acquired":true,"shares":38700,"price":18.61,"value":720207.0,"ownership":{"direct":false,"nature":"By John Patience Trust dated 7/23/1993"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.50 to $18.63, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4171211,"source":{"system":"sec-edgar","filing":"0001144204-17-057234","document":"tv478969_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417057234/tv478969_4.xml","form_type":"4"}},{"id":4176855,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-11-01T18:22:37.000Z","date":"2017-10-31","kind":"grant","acquired":true,"shares":141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer."}],"balance_after":1776,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":141},"source":{"system":"sec-edgar","filing":"0001692742-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274217000056/edgardoc.xml","form_type":"4"}},{"id":4247813,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-01T17:53:41.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer receipt of the shares to which such person would otherwise be entitled upon vesting until such persons separation of service from the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer receipt of the shares to which such person would otherwise be entitled upon vesting until such persons separation of service from the issuer."}],"balance_after":1635,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":129},"source":{"system":"sec-edgar","filing":"0001692742-17-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274217000049/edgardoc.xml","form_type":"4"}},{"id":4303839,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-26T16:36:49.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":1506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer receipt of the shares to which such person would otherwise be entitled upon vesting until such persons separation of service from the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer receipt of the shares to which such person would otherwise be entitled upon vesting until such persons separation of service from the issuer."}],"balance_after":1506,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1506},"source":{"system":"sec-edgar","filing":"0001692742-17-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274217000030/edgardoc.xml","form_type":"4"}},{"id":4303838,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-26T16:36:49.000Z","date":"2017-05-25","kind":"exercise","acquired":false,"shares":495,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit(RSU) represents the right to receive, at settlement, one share of common stock. This transaction represents the full vesting of RSUs in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit(RSU) represents the right to receive, at settlement, one share of common stock. This transaction represents the full vesting of RSUs in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit(RSU) represents the right to receive, at settlement, one share of common stock. This transaction represents the full vesting of RSUs in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit(RSU) represents the right to receive, at settlement, one share of common stock. This transaction represents the full vesting of RSUs in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2017-05-25","underlying":"Common Stock","underlying_shares":495},"source":{"system":"sec-edgar","filing":"0001692742-17-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274217000030/edgardoc.xml","form_type":"4"}},{"id":4303837,"issuer":{"id":80873,"kind":"organization","name":"STERICYCLE INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T16:36:49.000Z","date":"2017-05-25","kind":"exercise","acquired":true,"shares":495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit(RSU) represents the right to receive, at settlement, one share of common stock. This transaction represents the full vesting of RSUs in shares of common stock on their scheduled vesting date."}],"balance_after":149629,"source":{"system":"sec-edgar","filing":"0001692742-17-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861878/000169274217000030/edgardoc.xml","form_type":"4"}},{"id":4363907,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-04-04T19:07:04.000Z","date":"2017-04-01","kind":"grant","acquired":true,"shares":11721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2017."}],"balance_after":11721,"derivative":{"exercise_price":24.2,"expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":11721},"source":{"system":"sec-edgar","filing":"0001144204-17-018992","document":"v463574_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417018992/v463574_4.xml","form_type":"4"}},{"id":4494577,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-10T19:31:11.000Z","date":"2017-01-09","kind":"purchase","acquired":true,"shares":39500,"price":19,"value":750500.0,"ownership":{"direct":false,"nature":"By Patience Enterprises LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2110662,"source":{"system":"sec-edgar","filing":"0001144204-17-001696","document":"v456704_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417001696/v456704_4.xml","form_type":"4"}},{"id":4494576,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-10T19:31:11.000Z","date":"2017-01-09","kind":"purchase","acquired":true,"shares":13200,"price":19,"value":250800.0,"ownership":{"direct":false,"nature":"By John Patience Trust dated 7/23/1993"},"balance_after":4132511,"source":{"system":"sec-edgar","filing":"0001144204-17-001696","document":"v456704_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420417001696/v456704_4.xml","form_type":"4"}},{"id":4522974,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-12-14T16:35:43.000Z","date":"2016-12-13","kind":"exercise","acquired":false,"shares":24670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.48,"exercise_date":"2014-04-03","expiration_date":"2023-04-03","underlying":"Common Stock","underlying_shares":24670},"source":{"system":"sec-edgar","filing":"0001144204-16-139501","document":"v455035_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420416139501/v455035_4.xml","form_type":"4"}},{"id":4522973,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T16:35:43.000Z","date":"2016-12-13","kind":"exercise","acquired":true,"shares":24670,"price":6.48,"value":159861.6,"ownership":{"direct":true},"balance_after":44670,"source":{"system":"sec-edgar","filing":"0001144204-16-139501","document":"v455035_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420416139501/v455035_4.xml","form_type":"4"}},{"id":4530599,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-12-07T20:55:15.000Z","date":"2016-12-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total number of stock options held by the reporting person was previously aggregated in Table II of the reporting person's previous Form 4s.  The number of stock options reported on this Form 4 reflects only the number of stock options of the class reported herein."}],"balance_after":24670,"derivative":{"exercise_price":6.48,"exercise_date":"2014-04-03","expiration_date":"2023-04-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-16-138466","document":"v454647_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/727207/000114420416138466/v454647_4.xml","form_type":"4"}}],"next_cursor":"2016-12-07T20:55:15.000000Z,4530599"}